Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine spray for prevention of postoperative nausea and vomiting
ChiCTR2300073839Phase 4Completed
- Sponsor
- The Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by The Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Incidence of postoperative nausea and vomiting. Started Jul 2023; status: completed.
02
Drugs
lidocaine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2300073839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073839.